\n Additional company office in the Asia Pacific region will showcase Vetter’s expertise and help build and strengthen its business network in China <\/p>\n
- \n
- New office underscores importance of Chinese market<\/b><\/li>\n
- Physical presence promotes
\ndevelopment of new business in China<\/b><\/li>\n- Comprehensive service portfolio
\nsupports domestic companies in accessing the\u00a0<\/b>global market place<\/b><\/li>\n<\/ul>\n
\n
\n
\n <\/p>\nSHANGHAI, CHINA AND RAVENSBURG, GERMANY\u00a0–\u00a0Media
\nOutReach<\/a>\u00a0–\u00a08 March 2021 <\/b>-
\nVetter<\/a>, one of the global leaders in prefilled drug-delivery
\nsystems, today announced the opening of a new business entity in Shanghai, China.
\nThe new office, now its fourth in the Asia
\nPacific (APAC) region<\/a>,
\nwill help increase the visibility of Vetter’s presence in China and underlines its
\nimportance as an important strategic market to Vetter. Thus, the office will
\nsupport customer relations and aid in the development of new business. As the
\nsecond largest pharmaceutical market and one of the largest in sales growth
\nrate worldwide, China offers a promising injectable pipeline and allows the
\nContract Development and Manufacturing Organization (CDMO) to offer support to domestic
\ncompanies that plan on bringing their molecules to the global market. <\/b>As a strategic partner, Vetter
\nsupports its worldwide customer base through every phase of their injectable
\ndrug product’s lifecycle, from early development
\nactivities<\/a>
\nto commercial supply<\/a> up to lifecycle initiatives<\/a>.<\/p>\n![](\"https:\/\/release.media-outreach.com\/release.php\/Images\/Thumb\/500x0\/129927\/Vetter-image.jpg#image-129927\")
<\/p>\n
\n <\/p>\nVetter’s
\nnew office underscores the importance of the Chinese market for the
\npharmaceutical service provider. <\/i>Oskar
\nGold, Chervee Ho, and Jason Zhong (from left to right) act as key contacts.
\n <\/p>\nSource: Vetter Pharma International GmbH<\/i><\/span><\/p>\n
\n
\n
\n <\/p>\n“We are convinced that our continued
\ninvestment in the Asia Pacific region will significantly contribute to our
\nfuture global growth,” explained Vetter Managing Director Peter Soelkner. “With
\nan increased share of Asian firms among the Top 50 Pharma companies worldwide over
\nthe last several years, our mission is to service the needs of our global customer
\nbase, of course including Asia, in the best-possible way.” Oskar Gold, Vetter’s
\nSenior Vice President for Asia Pacific\/Emerging Global Markets outlined the
\ninitiative: “Our presence in China demonstrates our dedication in one of the
\nmost important markets of the APAC region and will help to increase the awareness
\nof Vetter’s services by presenting our expertise and market position onsite.” The
\noffice is staffed by Mr. Jason Zhong, who assumes the position of Business
\nDevelopment Manager China. As the first member of the new team in China,
\nMr. Zhong will lead Vetter’s business activities reporting to Ms. Chervee Ho,
\nwho is Vetter’s Director Key Account Management Asia Pacific, based in
\nSingapore. <\/p>\n
\n <\/p>\n\u00a0<\/p>\n
\n <\/p>\nThe new office, located in Puxi,
\nShanghai, is strategically positioned on Nanjing Road West in the heart of the
\ncity’s Central Business District. Its creation follows Vetter’s business
\ndevelopment activities in its APAC regional office in Singapore, as well as in
\nits sales offices in Japan and South Korea, further <\/i>strengthening its
\nfootprint in the Asia Pacific region. <\/p>\n
\n <\/p>\n\u00a0<\/p>\n
\n <\/p>\nFind
\nthe Vetter press kit and more bac<\/b><\/span>kground information<\/b><\/span> <\/b><\/span>here<\/b><\/a>.<\/b> - Physical presence promotes